• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习的决策模型在胃癌术前帮助临床医生决定淋巴结清扫范围(D1 与 D2)的性能。

Performance of a machine learning-based decision model to help clinicians decide the extent of lymphadenectomy (D1 vs. D2) in gastric cancer before surgical resection.

机构信息

Department of Radiology, TongDe Hospital of ZheJiang Province, No. 234, Gucui Road, Hangzhou, 310012, Zhejiang, China.

Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, No. 300, Guangzhou Road, Nanjing, 210009, Jiangsu, China.

出版信息

Abdom Radiol (NY). 2019 Sep;44(9):3019-3029. doi: 10.1007/s00261-019-02098-w.

DOI:10.1007/s00261-019-02098-w
PMID:31201432
Abstract

BACKGROUND

Controversy still exists on the optimal surgical resection for potentially curable gastric cancer (GC). Use of radiologic evaluation and machine learning algorithms might predict extent of lymphadenectomy to limit unnecessary surgical treatment. We purposed to design a machine learning-based clinical decision-support model for predicting extent of lymphadenectomy (D1 vs. D2) in local advanced GC.

METHODS

Clinicoradiologic features available from routine clinical assignments in 557 patients with GCs were retrospectively interpreted by an expert panel blinded to all histopathologic information. All patients underwent surgery using standard D2 resection. Decision models were developed with a logistic regression (LR), support vector machine (SVM) and auto-encoder (AE) algorithm in 371 training and tested in 186 test data, respectively. The primary end point was to measure diagnostic performance of decision model and a Japanese gastric cancer treatment guideline version 4th (JPN 4th) criteria for discriminate D1 (pT1 + pN0) versus D2 (≥ pT1 + ≥ pN1) lymphadenectomy.

RESULTS

The decision model with AE analysis produced highest area under ROC curve (train: 0.965, 95% confidence interval (CI) 0.948-0.978; test: 0.946, 95% CI 0.925-0.978), followed by SVM (train: 0.925, 95% CI 0.902-0.944; test: 0.942, 95% CI 0.922-0.973) and LR (train: 0.886, 95% CI 0.858-0.910; test: 0.891, 95% CI 0.891-0.952). By this improvement, overtreatment was reduced from 21.7% (121/557) by treat-all pattern, to 15.1% (84/557) by JPN 4th criteria, and to 0.7-0.9% (4-5/557) by the new approach.

CONCLUSIONS

The decision model with machine learning analysis demonstrates high accuracy for identifying patients who are candidates for D1 versus D2 resection. Its approximate 14-20% improvements in overtreatment compared to treat-all pattern and JPN 4th criteria potentially increase the number of patients with local advanced GCs who can safely avoid unnecessary lymphadenectomy.

摘要

背景

对于潜在可治愈的胃癌(GC),最佳手术切除范围仍存在争议。放射学评估和机器学习算法的使用可能有助于预测淋巴结清扫范围,以限制不必要的手术治疗。我们旨在设计一种基于机器学习的临床决策支持模型,用于预测局部晚期 GC 的淋巴结清扫范围(D1 与 D2)。

方法

回顾性分析了 557 例 GC 患者的临床影像学特征,这些特征均由一个专家小组从常规临床任务中获得,该专家小组对所有组织病理学信息均不知情。所有患者均采用标准的 D2 切除术进行手术。使用逻辑回归(LR)、支持向量机(SVM)和自动编码器(AE)算法分别在 371 例训练数据和 186 例测试数据中建立决策模型。主要终点是衡量决策模型和日本胃癌治疗指南第 4 版(JPN 4th)标准对 D1(pT1+ pN0)与 D2(≥ pT1+ ≥ pN1)淋巴结清扫的诊断性能。

结果

AE 分析的决策模型产生了最高的 ROC 曲线下面积(训练:0.965,95%置信区间 [CI] 0.948-0.978;测试:0.946,95% CI 0.925-0.978),其次是 SVM(训练:0.925,95% CI 0.902-0.944;测试:0.942,95% CI 0.922-0.973)和 LR(训练:0.886,95% CI 0.858-0.910;测试:0.891,95% CI 0.891-0.952)。通过这种改进,与全治疗模式相比,过度治疗从 21.7%(121/557)减少到 JPN 4 版标准的 15.1%(84/557),再减少到新方法的 0.7-0.9%(4-5/557)。

结论

基于机器学习分析的决策模型在识别适合 D1 与 D2 切除的患者方面具有很高的准确性。与全治疗模式和 JPN 4 版标准相比,其在过度治疗方面提高了约 14-20%,这可能会增加可以安全避免不必要淋巴结清扫的局部晚期 GC 患者数量。

相似文献

1
Performance of a machine learning-based decision model to help clinicians decide the extent of lymphadenectomy (D1 vs. D2) in gastric cancer before surgical resection.基于机器学习的决策模型在胃癌术前帮助临床医生决定淋巴结清扫范围(D1 与 D2)的性能。
Abdom Radiol (NY). 2019 Sep;44(9):3019-3029. doi: 10.1007/s00261-019-02098-w.
2
Resection for gastric cancer in the community.社区胃癌切除术
Semin Oncol. 2005 Dec;32(6 Suppl 9):S90-3. doi: 10.1053/j.seminoncol.2005.06.010.
3
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.胃癌的外科治疗:随机全国性荷兰 D1D2 试验的 15 年随访结果。
Lancet Oncol. 2010 May;11(5):439-49. doi: 10.1016/S1470-2045(10)70070-X. Epub 2010 Apr 19.
4
[Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].[胃癌全胃切除术:淋巴结清扫类型会影响长期疗效吗?]
Suppl Tumori. 2005 May-Jun;4(3):S84-5.
5
An Intelligent Clinical Decision Support System for Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer.用于胃癌淋巴结转移术前预测的智能临床决策支持系统。
J Am Coll Radiol. 2019 Jul;16(7):952-960. doi: 10.1016/j.jacr.2018.12.017. Epub 2019 Feb 4.
6
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.胃癌D1和D2切除术后患者的生存率:MRC随机外科试验的长期结果。外科合作组。
Br J Cancer. 1999 Mar;79(9-10):1522-30. doi: 10.1038/sj.bjc.6690243.
7
Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.胃腺癌淋巴结清扫的最佳范围:美国胃癌协作组的一项7机构研究
J Surg Oncol. 2016 Jun;113(7):750-5. doi: 10.1002/jso.24227. Epub 2016 Mar 21.
8
A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.单一西方中心多位外科医生行 D1 与 D2 胃切除术的手术结局比较:倾向评分匹配的回顾性分析。
World J Surg Oncol. 2018 Jul 9;16(1):136. doi: 10.1186/s12957-018-1422-6.
9
Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.临床情况不佳患者行 D1 淋巴结清扫术的胃切除术的手术结果。
Eur J Surg Oncol. 2019 Mar;45(3):460-465. doi: 10.1016/j.ejso.2018.11.013. Epub 2018 Nov 22.
10
[Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].[Rebagliati医院进展期胃癌D1与D2淋巴结清扫术的对比研究]
Rev Gastroenterol Peru. 2006 Oct-Dec;26(4):351-6.

引用本文的文献

1
Bridging technology and medicine: artificial intelligence in targeted anticancer drug delivery.连接技术与医学:人工智能在靶向抗癌药物递送中的应用
RSC Adv. 2025 Aug 4;15(34):27795-27815. doi: 10.1039/d5ra03747f. eCollection 2025 Aug 1.
2
Predictive value of enhanced CT and pathological indicators in lymph node metastasis in patients with gastric cancer based on GEE model.基于广义估计方程(GEE)模型的增强CT及病理指标对胃癌患者淋巴结转移的预测价值
BMC Med Imaging. 2025 Feb 3;25(1):36. doi: 10.1186/s12880-025-01577-5.
3
Advanced CNN models in gastric cancer diagnosis: enhancing endoscopic image analysis with deep transfer learning.
用于胃癌诊断的先进卷积神经网络模型:通过深度迁移学习增强内镜图像分析
Front Oncol. 2024 Sep 16;14:1431912. doi: 10.3389/fonc.2024.1431912. eCollection 2024.
4
Computational Approaches: A New Frontier in Cancer Research.计算方法:癌症研究的新前沿。
Comb Chem High Throughput Screen. 2024;27(13):1861-1876. doi: 10.2174/0113862073265604231106112203.
5
Machine learning applications in upper gastrointestinal cancer surgery: a systematic review.机器学习在消化道上部癌症手术中的应用:系统评价。
Surg Endosc. 2023 Jan;37(1):75-89. doi: 10.1007/s00464-022-09516-z. Epub 2022 Aug 11.
6
Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents.人工智能在抗癌和抗糖尿病治疗药物发现与开发中的应用。
Evid Based Complement Alternat Med. 2022 Apr 25;2022:6201067. doi: 10.1155/2022/6201067. eCollection 2022.
7
Hybrid Deep Learning Model for Endoscopic Lesion Detection and Classification Using Endoscopy Videos.使用内镜视频的用于内镜病变检测与分类的混合深度学习模型
Diagnostics (Basel). 2021 Dec 26;12(1):43. doi: 10.3390/diagnostics12010043.
8
Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning.基于机器学习预测胃癌患者的腹膜转移。
Cancer Control. 2020 Jan-Dec;27(1):1073274820968900. doi: 10.1177/1073274820968900.